跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,042 条关于
“Dopamine D2 receptor”
全部
13,042
临床试验
6,382
药物
1,444
机构
30
资讯
5,186
去年
IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression
10个月前
NG101 Shows Promise in Phase 2 Trial for GLP-1-Induced Nausea and Vomiting
18天前
Drug repurposing screen identifies dopamine signaling and COX inhibition as candidate therapeutic pathways for PIGA-CDG
去年
Bristol Myers Squibb Soars as AbbVie's Schizophrenia Drug Fails Trial
8个月前
Renexxion Secures Sixth U.S. Patent for Naronapride Trihydrate Formulation Targeting Multiple GI Disorders
去年
AbbVie's Emraclidine Fails to Meet Endpoints in Phase 2 Schizophrenia Trials
2个月前
First In Vivo PET Evidence Reveals Widespread M1 Receptor Deficits in Living Schizophrenia Patients
3年前
Ropinirole Shows Promise in ALS Treatment by Extending Progression-Free Survival in Phase 1/2a Trial
4个月前
FDA Approves Caplyta for Schizophrenia Relapse Prevention Based on Phase III Data
2年前
TAK-906: Peripheral D2/D3 Antagonist Under Development for Gastroparesis
第 1 页,共 519 页
上一页
下一页